Literature DB >> 2648923

Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level.

A M Garber1, H C Sox, B Littenberg.   

Abstract

From our review of the epidemiologic and clinical literature, we have developed recommendations for using the serum cholesterol test as a component of strategies to prevent coronary heart disease in asymptomatic adults. Total cholesterol, high-density lipoprotein, and low-density lipoprotein levels are risk factors for coronary disease and early mortality in middle-aged men. Weaker evidence suggests that hypercholesterolemia increases the risk for coronary disease in women or elderly men, or that hypertriglyceridemia increases the risk in men or women. A reduction in cholesterol levels lowers the incidence of and the mortality from coronary disease in asymptomatic, hypercholesterolemic, middle-aged men, but has not been shown to reduce overall mortality. The efficacy of treatment in women and elderly persons has not been studied. Screening and treatment plans should be individualized; a 5-year period between tests is adequate for asymptomatic, low-risk men, whereas more frequent testing is appropriate for high-risk men. Screening is optional for women and elderly persons.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648923     DOI: 10.7326/0003-4819-110-8-622

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  6 in total

1.  Asymptomatic hypertriglyceridaemia.

Authors:  S B Hulley; A L Avins
Journal:  BMJ       Date:  1992-02-15

2.  The yield of cholesterol screening in an urban black community.

Authors:  N K Russell; D M Becker; C P Finney; H Moses
Journal:  Am J Public Health       Date:  1991-04       Impact factor: 9.308

3.  What should be done about asymptomatic hypercholesterolaemia?

Authors:  G R Thompson
Journal:  BMJ       Date:  1991-03-16

Review 4.  Radiographically detectable calcium and atherosclerosis: the connection and its exploitation.

Authors:  R Detrano; S Molloi
Journal:  Int J Card Imaging       Date:  1992

5.  Cholesterol-lowering therapy: what patients expect in return.

Authors:  W W Reed; J E Herbers; G L Noel
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128

6.  The Bioequivalence and Effect of Food on the Pharmacokinetics of a Fixed-Dose Combination Tablet Containing Rosuvastatin and Ezetimibe in Healthy Japanese Subjects.

Authors:  Chisato Nishida; Yuki Matsumoto; Katsukuni Fujimoto; Masayoshi Shirakawa; Rebecca Ellen Wrishko; Martin Otto Behm; Kenichi Furihata
Journal:  Clin Transl Sci       Date:  2019-09-26       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.